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Background   Cemented total hip arthroplasty has been the treat-
ment of choice for elderly patients with osteoarthritis. We ana-
lyzed survival rates of the most common cementless designs used 
in this age group in Finland. 
Patients  and  methods      Inclusion  criteria  permitted  10,310 
replacements (8 designs) performed in patients aged 55 years or 
older to be selected for evaluation. The risk of revision of each of 
the 8 implants was compared with that of a group comprising 3 
cemented designs as the reference (9,549 replacements). Survival 
analyses were performed overall and separately for 3 age cohorts: 
55–64  years  (6,781  replacements),  65–74  years  (8,821  replace-
ments), and 75 years or older (4,257 replacements).
Results   In all patients aged 55 years or more, the Bi-Metric 
stem had a higher survival rate for aseptic loosening at 15 years 
than the cemented reference group: 96% (95% CI: 94–98) vs. 
91% (CI: 90–92). However, the 15-year survival rates of the Bi-
Metric/Press-Fit Universal (71% (CI: 67–75)) and the Anatomic 
Mesh/Harris-Galante II (72% (CI: 67–78)) total hip replacements 
were lower than that of the reference group (86% (CI: 84–87)). 
Information was scarce for patients aged 75 years or more.
Interpretation   Cementless proximal porous-coated stems are 
a good option for elderly patients. Even though biological fixation 
is a reliable fixation method in THA, polyethylene wear and oste-
olysis remain a serious problem for cementless cup designs with 
unplugged screw holes and low-quality liners.

Results  obtained  from  the  Scandinavian  arthroplasty  regis-
tries (Havelin et al. 2000, Puolakka et al. 2001a, Malchau et 
al. 2002) on a nation-by-nation basis and studies from single 
centers worldwide (Berry et al. 2002, Wroblewski et al. 2002, 
Della Valle et al. 2004, Buckwalter et al. 2006, Morshed et 
al. 2007) have indicated that cemented total hip replacement 
is the treatment of choice for severe osteoarthritis in elderly 
patients. However, in a recent study based on data obtained 
from the Finnish Arthroplasty Register, cementless implants 
were  found  to  have  similar  long-term  survival  rates  as 
cemented implants in patients aged 55 years or more (Mäkelä 
et al. 2008a). Several studies (Archibeck et al. 2001, Bojescul 
et al. 2003, Jacobsen et al. 2003, Marshall et al. 2004, Meding 
et al. 2004, Oosterbos et al. 2004, Parvizi et al. 2004) have 
shown that the survival rates of cementless stems have been 
satisfactory for all age groups, but cementless cups have a 
common problem of liner wear, osteolysis, and high incidence 
of revision in the medium-to-long term (Barrack et al. 1997, 
Malchau et al. 1997, Havelin et al. 2002, Duffy et al. 2004). 
We therefore separately analyzed the survival rates of the 
most  common  cementless  designs  performed  for  primary 
osteoarthritis in patients aged 55 years or older in Finland, 
and compared the risk of revision for each implant with that of 
the cemented implant reference group (Mäkelä et al. 2008b). 
These  analyses  were  carried  out  on  population-based  data 
obtained from the Finnish Arthroplasty Register for the period 
1980 through 2005.
Patients and methods 
Since 1980, data on total hip replacements have been collected 
and  archived  in  the  Finnish Arthroplasty  Register  (Paavol-
ainen et al. 1991, Puolakka et al. 2001a). Healthcare authori-
ties, institutions, and orthopedic units in Finland are obliged to 
provide the National Agency for Medicines with information 
that is essential for monitoring past and current trends for the 
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orthopedics. The coverage in the Finnish Arthroplasty Register 
was initially analyzed for the period 1994–1995 by comparing 
its data with those of the discharge registers of participating 
hospitals; the Register covered 90% of all implantations per-
formed (Puolakka et al. 2001a). Since 1995, the data in the 
register have been compared with those of hospital discharge 
registers every few years. Currently, 98% of implantations are 
recorded in the Finnish Arthroplasty Register (Peltola 2008).
Study population and inclusion criteria
During the study period (1980–2005), 101,720 primary total 
hip replacements were performed in Finland. Of these, 87,578 
(86%) were performed on patients aged 55 years or older. 
Primary osteoarthritis was the indication in 71,146 (81%) of 
these operations; cementless total hip implants were used in 
30,112 (42%). 
Only designs used in more than 500 operations during the 
study period and designs with more than 20 hips at risk at 5 
years were included in the current study. These criteria permit-
ted the inclusion of 8 designs (10,310 replacements) (Table 1). 
The risk of revision for each design was compared with that 
for 9,549 cemented reference implants (Table 2). A 10-year 
survival rate exceeding 90% is commonly regarded as a good 
long-term outcome (National Institute of Clinical Excellance, 
NICE). The 3 best performing cemented designs in Finland 
(Mäkelä et al. 2008b) fulfilled this criterion and were chosen as 
Table 1. Demographic data of the implants analyzed
THR Brands  No.   Mean    Mean    Women   No. of    Period of 
     follow-up  age  (%)  hospitals  implantation
Anatomic Mesh/HG-II   604   11.1   63   56   24   1989–1997
PCA Std/PCA Pegged   508   11.6   63   55   23   1985–1995
Bi-Metric/PFU   2,687   8.8   63   49   53   1986–2001
Bi-Metric/Mallory   637   8.7   67  60   11   1989–2000
Bi-Metric/Vision   2,055   3.4   65   48   47   1998–2005
ABG I/ABG I   565   9.1   65   55   25   1992–1997
ABG I/ABG II   1,765   5.9   66   51   36   1996–2003
ABG II/ABG II   1,489   2.5   67   55   31   2000–2005
Cemented reference   9,549   8.8   72   66  62   1980–2005
Together   19,859   7.6   68   59   77   1980–2005
HG-II: Harris-Galante II; PCA Std: porous-coated Anatomic Standard; PFU: Press-Fit Universal; 
ABG: Anatomique Benoist Girard.
Table 2. Material, surface, design features, and manufacturer of the implants. For abbreviations, see Table 1
THR Brands  Material   Surface   Special design features  Manufacturer
Stems    
  Bi-Metric   Titanium alloy   Proximally porous-coated   Straight, collarless   Biomet
  Anatomic Mesh   Titanium alloy   Proximally porous-coated    Anatomic   Zimmer
  ABG I   Titanium alloy   Proximally grit-blasted and HA-coated   Anatomic   Stryker Howmedica
  ABG II   Titanium alloy   Proximally grit-blasted and HA-coated   Anatomic    Stryker Howmedica
  PCA Standard   CoCr alloy    Proximally porous-coated   Anatomic   Stryker Howmedica
  Exeter Universal   Stainless steel   Polished   Straight, collarless,     Stryker Howmedica
        cemented
  Müller Straight   CoCr alloy   Matt   Straight, small collar,    Zimmer
       fluted macrostructure
  Lubinus SP II   CoCr alloy   Matt   Anatomic, collar, modular    Link
Cups    
  ABG I   Titanium alloy   Grit-blasted and HA-coated   Hemispherical,   Stryker 
        open screw-holes   Howmedica
  ABG II   Titanium alloy   Grit-blasted and HA-coated  Hemispherical, screw-holes     Stryker Howmedica   
        plugged
  Biomet Mallory   Titanium alloy   Porous-coated   Hemispherical, open screw-holes, fins    Biomet
  Biomet Universal  Titanium alloy   Porous-coated    Hemispherical, open screw-holes   Biomet
  Biomet Vision   Titanium alloy   Porous-coated    Hemispherical, screw-holes plugged   Biomet
  Harris-Galante II  Titanium alloy   Porous-coated    Hemispherical, open screw-holes   Zimmer
  PCA Pegged   Cobalt-chromium  Porous-coated    Hemispherical, open screw-holes   Stryker Howmedica
  Exeter All-poly    Polyethylene    –   Cemented   Stryker Howmedica
  Müller Std   Polyethylene   –    Cemented   Zimmer
  Lubinus IP   Polyethylene   –     Groove design   Link44  Acta Orthopaedica 2010; 81 (1): 42–52
reference implants. These 3 cemented designs were the Exeter 
Universal  stem  combined  with  the  All-poly  cup  (Stryker, 
Mahwah, NJ), the Müller Straight stem combined with the 
Müller Standard cup (Zimmer, Warsaw, IN), and the Lubinus 
SP II stem combined with the Lubinus IP cup (Waldemer Link, 
Hamburg, Germany). Survival analyses were performed for 
the whole study population and separately for each of 3 age 
cohorts: 55–64 years, 65–74 years, and 75 years and older. The 
data from subgroup analysis were massive and only the data 
with “any reason” as cause of revision are presented (Table 7).
Revisions were linked to the primary operation by using the 
patient’s personal identification number; these numbers are 
assigned to every resident of Finland. Numbers and indica-
tions for revision were recorded (Table 3).
Statistics
The endpoint for survival was defined as revision when any 
component (including femoral head and liner) or the whole 
implant was removed or exchanged. Survival rates for stems 
and cups were analyzed separately with revision for aseptic 
loosening being used as the endpoint. When survival analy-
ses were conducted for total hip replacements (cup + stem 
combinations), both revision for any reason and revision for 
aseptic loosening served as discrete endpoints. Kaplan-Meier 
survival  analysis  was  used  to  calculate  the  survival  prob-
abilities of implants at 7, 10, and 15 years. The survival rate 
of any respective implant was determined only when there 
were at least 20 hips at risk at the follow-up point (Furnes et 
al. 2001). Patients who had died or emigrated from Finland 
during the follow-up period were censored at that point. Sur-
vival data obtained by Kaplan-Meier analysis were compared 
by the log-rank test. The Cox multiple regression model was 
used to study differences between implants and to adjust for 
potential confounding factors. 
Both Kaplan-Meier and Cox regression are methods based 
on assumptions of independent observations. However, bilat-
eral observations cannot be regarded as being independent 
(Robertsson and Ranstam 2003, Bryant et al. 2006). Violation 
of this independence assumption may have an effect on the 
validity of the results. To avoid this violation, the data analysis 
could be performed by allowing inclusion of correlated obser-
vations, e.g. including only one prosthesis per patient or by 
including a shared frailty variable in the Cox regression. In the 
current study, however, bilateral observations were included 
in the dataset analyzed. It has been found that the effect of 
neglecting bilateral prostheses is minute (Havelin et al. 1995, 
Robertsson and Ranstam 2003, Lie et al. 2004). 
Risk of revision ratios of stems, cups, and total hip replace-
ments  (cup  +  stem  combinations)  were  analyzed. Adjust-
ments  were  made  for  age  and  sex.  The  3  best  perform-
ing cemented designs in Finland were chosen as reference 
implants (Mäkelä et al. 2008b). The survival data of these 
cemented designs were combined to form a single reference 
group. Cox regression analyses provided survival probabili-
ties and adjusted risk ratios for revision. Estimates derived 
from the Cox analyses were used to construct adjusted sur-
vival curves at mean values of the risk factors. The propor-
tional hazards assumption of the Cox model (meaning that 
the relative difference between revision rates should be con-
stant over time since the primary operation) was not reached 
Table 3. Reasons for revision of the 8 most common cementless brands and the cemented reference designs. Percentage in parentheses. 
For prosthesis types, see Table 1
  A  B  C  D  E  F  G  H  I  J  K  L       
Anatomic Mesh/HG-II   604   17 (15)   23 (20)   17 (15)  0 (0)   4 (4)   7 (6)   4 (4)   2 (2)   39 (35)   113 
PCA Std/PCA Pegged   508   19 (14)   81 (60)   19 (14)   2 (2)   1 (1)   2 (2)   0 (0)   1 (1)   10 (7)   135 
Bi-Metric/PFU   2,687   26 (8)   67 (19)   10 (3)   9 (3)   57 (17)   14 (4)   16 (5)   15 (4)   131 (38)  345 
Bi-Metric/Mallory   637   5 (8)   11 (17)   3 (5)   1 (2)   12 (19)   3 (5)   5 (8)   3 (5)   21 (33)   64 
Bi-Metric/Vision   2,055   11 (16)   1 (1)   6 (9)   8 (12)   28 (41)   5 (7)   0 (0)   4 (6)   6 (9)   69 
ABG I/ABG I   565   10 (9)   27 (26)   3 (3)   1 (1)   6 (6)   3 (3)   3 (3)   6 (6)   47 (44)   106 
ABG I/ABG II   1,765   1 (2)   6 (10)   2 (3)   5 (8)   13 (21)   10 (16)   1 (2)   10 (16)   15 (24)   63 
ABG II/ABG II   1,489   2 (4)   1 (2)   3 (6)   3 (6)   10 (20)   7 (14)   4 (8)   19 (37)   2 (4)   51 
Cemented reference   9,549  227 (28)   142 (18)   253 (32)   38 (5)   73 (9)   20 (3)   5 (1)   24 (3)   16 (2)   798 
Together   19,859  318 (18)    359 (21)   316 (18)   67 (4)   204 (12)  71 (4)   38 (2)   84 (5)  287 (17)  1,744 
A  THR brand  
B  No. of   primary operations
C  Aseptic loosening (cup + stem)
D  Aseptic loosening  (cup)  
E  Aseptic loosening (stem)
F  Infection 
G  Dislocation 
H  Malposition 
I  Fracture of the prosthesis 
J  Periprosthetic fracture  
K  Any other reason 
L  Together           Acta Orthopaedica 2010; 81 (1): 42–52  45
in some analyses performed. Thus, adjusted risk ratios were 
also established within time intervals (0–7 years, 7 years after 
the primary operation). The Wald test was used to calculate 
the p-values for data obtained from the Cox multiple regres-
sion analyses. A difference between groups was considered 
to be statistically significant if the p-value was less than 0.05 
in a two-tailed test.
Results
Survival of stems – aseptic loosening
When all patients aged 55 years or more were analyzed as a 
single group, the Bi-Metric stem had a higher survival rate at 
15 years than the reference group. The Cox regression analy-
sis revealed that all cementless stems studied had a statistically 
significantly reduced risk of revision during the first 7 years 
after the primary operation when compared to the reference 
group (Table 4). Beyond 7 years of follow-up, the Bi-Metric 
and the ABG I stems still showed significantly lower revision 
risks than the cemented reference group (Table 4, Figure 1A).
For the age groups 55–64 years and 65–74 years, the Bi-
Metric stem had a higher 15-year survival rate than the refer-
ence group (95% (CI: 92–97) vs. 84% (CI: 80–87) and 98% 
(CI: 97–99) vs. 90% (CI: 89–91), respectively).
Survival of cups – aseptic loosening
When all patients aged 55 years or more were analyzed as 
a single group, the survival of the PCA Pegged cup at 15 
years was lower than that of the reference group. Apart from 
this exception, there were no differences in survival rates 
between cementless cups and that of the reference group at 
15-years. The Cox regression analysis revealed that the PCA 
Pegged cup had a significantly increased risk of revision both 
during the first 7 years postoperatively and beyond 7 years of 
follow-up. Furthermore, during the first 7 years the Press-Fit 
Universal, the Mallory, the Vision, and the ABG II cups had 
significantly reduced risks of revision compared to the refer-
ence group (Table 5). Beyond 7 years of follow-up, however, 
the lower revision risk remained only for the Press-Fit Uni-
versal cup (Table 5, Figure 1B). The number of Vision and 
ABG II cups for analysis beyond 7 years was low (Table 5).
Table 4. Survival of cementless stems and the cemented reference group. Endpoint was defined as revision due to aseptic loosening of the 
stem. 7-, 10-, and 15-year survival rates were obtained from the Kaplan-Meier analysis. For prosthesis types, see Table 1
  A  B  C  D  E  F  G  H  I  J  K  L
All (≥ 55 years)  
  Anatomic Mesh   604   11.1   532   98 (97–99)   444   96 (94–98)   91   92 (89–95)   0.53 (0.37–0.76)   0.001
     FU ≤ 7 years                           0.38 (0.21–0.71)   0.002
      FU > 7 years                           0.64 (0.40–1.00)   0.05
   PCA Std   508   11.6   430   98 (96–99)   351   95 (92–97)   146   89 (86–93)   0.62 (0.44–0.88)   0.007
      FU ≤ 7 years                           0.49 (0.27–0.89)   0.02
      FU > 7 years                           0.68 (0.44–1.05)   0.08
   Bi-Metric   5,379   6.8   2,698   99 (99–99)   1,463  99 (98–99)   154   96 (94–98)   0.20 (0.15–0.27)   < 0.001
     FU ≤ 7 years                          0.18 (0.12–0.26)   < 0.001
      FU > 7 years                          0.24 (0.16–0.37)   < 0.001
   ABG I   2,330   6.7   1,152   100 (99–100)   342   98 (97–99)   0  –   0.15 (0.09–0.25)   < 0.001
      FU ≤ 7 years                          0.08 (0.04–0.18)   < 0.001
      FU > 7 years                           0.40 (0.20–0.80)   0.009
   ABG II   1,489   2.5   0   –   0   –   0   –  0.31(0.13–0.76)   0.01
      FU ≤ 7 years                           0.31 (0.13–0.76)   0.01 
      FU > 7 years                           –   –
   Cemented    9,549   8.8   6,231   97 (96–97)   4,442   95 (94–95)   1,115   91 (90–92)   1.0 (reference)   –
      FU ≤ 7 years                           1.0 (reference)   –
      FU > 7 years                           1.0 (reference)   –
  Total   19,859        
A  Age group 
B  Brand of stem 
C Number of operations 
D Mean follow-up (in years)  
E  At risk (7-year) 
F  % 7-year survival (95% CI) 
G At risk (10-year) 
H % 10-year survival (95% CI) 
I  At risk (15-year) 
J  % 15-year survival (95% CI) 
K  Adjusted RR a for revision (95% CI) 
L  p-value
a RR: risk ratio from the Cox regression analysis (other stem brands compared to the cemented reference stems, with adjustment made for age 
and sex)46  Acta Orthopaedica 2010; 81 (1): 42–52
For patients aged 55–64 years, the HG-II cup (87% (CI: 
82–91)) and the PFU cup (88% (CI: 84–93)) had similar sur-
vival rates at 15 years as the reference cups (85% (CI 81-
88)). For patients aged 65–74 years, the PFU cup had higher 
survival rate at 15 years than the reference group (96% (CI: 
94–98) vs. 92% (CI: 91–93)].
Figure 1. Cox-adjusted survival curves for 19,859 stems and 19,859 cups in patients aged 55 years or older with stem designs (panel A) or cup 
designs (panel B) as the strata factors. The endpoint was defined as stem (A) or cup (B) revision due to aseptic loosening. Adjustment was made 
for age and sex.  For an explanation of abbreviations, see Table 4.
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Table 5. Survival of cementless cups and the cemented reference group. Endpoint was defined as revision due to aseptic loosening of the 
cup. 7-, 10-, and 15-year survival rates were obtained from the Kaplan-Meier analysis. For abbreviations, see Table 4
  A  B  C  D  E  F  G  H  I  J  K  L
           
All (≥ 55 years) 
  HG-II   604   11.1   531  99 (98–100)   445  97 (95–98)   92  88 (84–92)   0.75 (0.53–1.05)    0.09
     FU ≤ 7 years                           0.50 (0.24–1.03)   0.0
     FU > 7 years                           0.82 (0.56–1.22)   0.3
  PCA Pegged   508   11.6   432   94 (92–96)   353  86 (83–89)   148  75 (70–80)   1.91 (1.49–2.44)   < 0.001
     FU ≤ 7 years                          2.21 (1.44–3.38)  < 0.001
     FU > 7 years                           1.70 (1.26–2.30)   < 0.001
   PFU   2,687   8.8   2,035   98 (97–99)   1,192  97 (96–98)   145  91 (87–94)  0.54 (0.42–0.70)   < 0.001
     FU ≤ 7 years                           0.68 (0.47–0.99)   0.04
     FU > 7 years                           0.45 (0.32–0.64)   < 0.001
  Mallory   637   8.8   517   99 (98–100)   275  96 (94–98)   10  –   0.52 (0.31–0.86)   0.01
     FU ≤ 7 years                          0.35 (0.14–0.85)   0.02       
     FU > 7 years                           0.68 (0.37–1.26)   0.2
  Vision   2,055   3.4   152   99 (98–100)   0   –   0  –   0.49 (0.27–0.89)   0.019
     FU ≤ 7 years                          0.51 (0.27–0.97)   0.04
     FU > 7 years                           3.39 (0.47–24.8)   0.2
  ABG I   565   9.1   454   98 (96–99)   330   93 (90–95)   0  –   1.17 (0.83–1.66)    0.4
     FU ≤ 7 years                          0.81 (0.43–1.52)   0.5
     FU > 7 years                           1.46 (0.96–2.24)   0.08
  ABG II   3,254   4.3   700   99 (99–100)   14   –  0  –  0.20 (0.11–0.38)   < 0.001
     FU ≤ 7 years                           0.22 (0.11–0.43)   < 0.001
     FU > 7 years                          0.19 (0.03–1.37)   0.1
  Cemented    9,549   8.8   6,221   98 (98–98)   4,441  96 (96–97)   1,113  92 (91–93)   1.0 (reference)   –
     FU ≤ 7 years                           1.0 (reference)  – 
     FU > 7 years                           1.0 (reference)  –
  Total   19,859        Acta Orthopaedica 2010; 81 (1): 42–52  47
Survival of total hip replacements (cup + stem com-
binations) – aseptic loosening
When all patients aged 55 years or more were analyzed as a 
single group, the 15-year survival of the PCA Standard/PCA 
Pegged was lower than that of the reference group. The Cox 
regression  analysis  revealed  that  the  PCA  Standard/PCA 
Pegged had a significantly increased risk of revision beyond 
7 years of follow-up. In contrast, all other cementless cup 
designs showed lower risk of revision than the cemented ref-
erence group during the first 7 years, and the Bi-Metric/Press-
Fit Universal, the Bi-Metric/Mallory, and the ABG I/ABGII 
even beyond 7 years (Figure 2A, Table 6). Beyond 7 years, the 
number of Bi-Metric/Vision THRs was low (Table 6).
For patients aged 55–64 years, the 15-year survival rate of 
the Bi-Metric/Press-Fit Universal was higher than that for 
the reference group (88% (CI: 84–92) vs. 78% (CI: 74–82)). 
For patients aged 65–74 years also, the survival rate at 15 
years of the Bi-Metric/Press-Fit Universal (95% (CI: 93–98)) 
was higher than that for the reference group (87% (CI: 86–
89%)). 
Survival of total hip replacements (cup + stem com-
binations) – all revisions
When all patients aged 55 years or more were analyzed as 
a single group, the survival rate at 15 years of the cement-
less designs was lower than that for the reference group. The 
Cox regression analysis revealed that during the first 7 years 
postoperatively, the ABG I/ABGII had a significantly reduced 
risk of revision compared to the cemented reference group 
(Table 7). Furthermore, the ABG II/ABG II combination was 
the only design to show an increased risk of revision during 
the first 7 years after the primary operation (Table 7). Beyond 
7 years of follow-up, however, several cementless designs (the 
Anatomic Mesh/HG-II, the PCA Standard/PCA Pegged, and 
the ABG I/ABG I) showed higher risk of revision than the 
cemented reference group (Table 7, Figure 2B), and none of 
the cementless designs had a lower risk of revision than the 
reference group beyond 7 years. Beyond 7 years, the number 
of ABG I/ABG II THRs was low (Table 7).
During the first 7 years postoperatively in the patients aged 
55–64 years, the risk ratio for revision of cementless THRs 
for any reason was not significantly different from that of 
the cemented reference group (Table 7). Beyond 7 years of 
follow-up, however, the revision risk of the Anatomic Mesh/
HG-II (RR = 1.6, CI: 1.2–2.2), the PCA Std/PCA Pegged (RR 
= 1.5, CI: 1.1–2.1), the Bi-Metric/PFU (RR = 1.5, CI: 1.1–
1.9), the Bi-Metric/Mallory (RR = 2.0, CI: 1.3–3.1), and the 
ABG I/ABG I (RR = 3.2, CI: 2.3–4.6) was higher than that of 
the reference group. 
During the first 7 years in the patients aged 65–74 years, the 
risk ratio for revision due of cementless THRs for any reason 
was not significantly different from that of the cemented ref-
erence group, except that the ABG I/ABG II had a reduced 
risk of revision compared to that of the reference group (RR 
= 0.45, CI: 0.28–0.72). Beyond 7 years of follow-up, the risk 
ratio for revision due of cementless THRs for any reason was 
not significantly different from that of the cemented reference 
group, except that the PCA Std/PCA Pegged (RR = 2.0, CI: 
Figure 2. Cox-adjusted survival curves for 19,859 total hip replacements in patients aged 55 years or older with total hip replacement design as 
the strata factor. The endpoint was defined as revision of the stem and/or the cup due to aseptic loosening (panel A) or as revision for any reason 
(B). Adjustment was made for age and sex. For an explanation of abbreviations, see Table 4.
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with poor results would be unlikely to have a major effect on 
the results in a study with such a high number of implants. 
Moreover, it is the purpose of registry studies to evaluate 
population-based results, including hospitals of variable stan-
dards. Another possible limitation of registry-based studies 
is their single definition of failure, i.e. a revision operation. 
There may be patients with osteolysis or loosened implants 
who are too ill to undergo revision surgery or who simply 
prefer not to do so. Furthermore, the adjustments in the Cox 
model in our study were performed only for 2 confound-
ers: age and sex. Many other potential confounders, such as 
antibiotic prophylaxis or hospital operative volume, may be 
associated with the relationship between implant brand and 
revision rate.
The implant designs varied over the long study period (Table 
1). Some of the 3 cemented designs we used as the reference 
group were implanted over the whole study period, starting 
in 1980. Any recent developments in cementing techniques 
that were adopted may have resulted in higher long-term sur-
vival rates for those prostheses that were implanted later in 
the study period (Herberts and Malchau 2000, Malchau et al. 
2002). However, the cemented implants we chose were the 
best performing designs in the Finnish Register regardless of 
the time period they were implanted (Mäkelä et al. 2008b). 
Table 6. Survival of cementless total hip replacements and the cemented reference group. Endpoint was defined as revision due to aseptic 
loosening of the cup and/or the stem. 7-, 10-, and 15-year survival rates were obtained from the Kaplan-Meier analysis. For abbreviations, 
see Table 4
  A  B  C  D  E  F  G  H  I  J  K  L
           
All (≥ 55 years) 
  Anatomic Mesh/HG-II   604   11.1   532   97 (96–98)   445   94 (92–96)   92   85 (80–89)   0.68 (0.51–0.90)   0.006
     FU ≤ 7 years                           0.52 (0.32–0.86)   0.01
     FU > 7 years                           0.75 (0.53–1.06)   0.1
  PCA Std/PCA Pegged   508   11.6   433   92 (90–95)   354   83 (80–87)   148   71 (66–76)   1.48 (1.19–1.83)   < 0.001
     FU ≤ 7 years                           1.37 (0.96–1.96)   0.09
     FU > 7 years                           1.46 (1.11–1.92)   0.006
   Bi-Metric/PFU   2,687   8.8   2,035   98 (97–98)   1,192   96 (96–97)   145   90 (87–93)   0.37 (0.29–0.46)    < 0.001
      FU ≤ 7 years                           0.39 (0.29–0.54)   < 0.001
      FU > 7 years                          0.34 (0.25–0.47)   < 0.001
   Bi-Metric/Mallory   637   8.8   517   99 (98–100)   275   96 (94–98)   10   –  0.36 (0.23–0.58)   < 0.001
      FU ≤ 7 years                           0.27 (0.13–0.55)   < 0.001
      FU > 7 years                          0.48 (0.26–0.88)   0.02
   Bi-Metric/Vision   2,055   3.4   152  99 (98–99)   0   –   0   –  0.37 (0.23–0.60)   < 0.001
      FU ≤ 7 years                           0.37 (0.23–0.62)  < 0.001
      FU > 7 years                           2.53 (0.35–18.4)  0.4
   ABG I/ABG I   565   9.1   455  97 (96–99)   330   92 (90–95)   0   –  0.75 (0.54–1.04)   0.09
      FU ≤ 7 years                           0.51 (0.29–0.87)   0.01
      FU > 7 years                           1.03 (0.68–1.55)   0.9
   ABG I/ABG II   1,765   5.9   700  99 (99–100)   14   –   0   –   0.12 (0.06–0.22)   < 0.001
      FU ≤ 7 years                           0.12 (0.06–0.24)   < 0.001
      FU > 7 years                           0.13 (0.02–0.93)   0.04
   ABG II/ABG II   1,489   2.5   0   –  0   –   0   –   0.33 (0.15–0.74)   0.007
      FU ≤ 7 years                           0.34 (0.15–0.76)   0.009
      FU > 7 years                           –   –
  Cemented   9,549   8.8   6,234   96 (96–96)   4,447   93 (93–94)   1,116   88 (87–89)   1.0 (reference)   –
     FU ≤ 7 years                          1.0 (reference)   –
      FU > 7 years                           1.0 (reference)   –
   Total   19,859        
 
1.3–3.3) had an increased risk of revision compared to the ref-
erence group. 
 
Discussion
We found that the survival rate for aseptic loosening of the 
best  performing  cementless  stems  in  patients  aged  55–74 
years was higher than that of the cemented reference stems. 
Biological fixation in itself seems to be a reliable method in 
THA of elderly patients. However, the survival rate of the 
cemented reference implants for any reason was higher than 
that of cementless implants. Polyethylene wear and osteolysis 
remain a serious problem with all cementless cup designs with 
unplugged screw-holes and poor liners. A longer follow-up 
is required in order to determine whether cups with plugged 
screw-holes and modern liner options provide any solution to 
the wear-problem. 
Registry-based studies have certain limitations. The cov-
erage of the Finnish Arthroplasty Register before the period 
1994–1995 was only 90% (Puolakka et al. 2001a). The miss-
ing 10% of implant data may have caused bias in our study. 
It is also possible that only a few centers performed most of 
the implantations of certain designs. However, a single center Acta Orthopaedica 2010; 81 (1): 42–52  49
Table 7. Survival of cementless total hip replacements and the cemented reference group. Endpoint was defined as revision of the cup 
and/or the stem for any reason. 7-, 10-, and 15-year survival rates were obtained from the Kaplan-Meier analysis. For an explanation of 
abbreviations, see Table 4
  A  B   C  D  E  F  G  H  I  J  K  L
55–64 
  Anatomic Mesh/HG-II   385   11.2   343   94 (92–97)   296  89 (86–92)   57   70 (64–76)   1.18 (0.91–1.54)   0.2
    PCA Std/PCA Pegged   347   12.2   303   91 (88–94)   262  82 (78–86)   119   66 (61–72)   1.32 (1.03–1.69)   0.03
  Bi-Metric/PFU   1,863   9.1   1,488   93 (92–94)   872  86 (85–88)   102   66 (61–72)   1.18 (0.97–1.44)   0.09
  Bi-Metric/Mallory   266   9.0   224   95 (92–97)   119  83 (77–88)   8   72 (61–82)   1.27 (0.90–1.80)   0.2
   Bi-Metric/Vision   1,080   3.8   96   95 (93–97)   0  –   0   –   1.05 (0.72–1.54)   0.8
   ABG I/ABG I   280   9.4   239   90 (87–94)   174  74 (69–80)   0   –   2.13 (1.62–2.81)  < 0.001
   ABG I/ABG II   746   6.0   309   95 (93–97)   6  –   0   –  0.90 (0.62–1.31)   0.6
   ABG II/ABG II   610   2.4   0   –   0  –   0   –   1.54 (0.93–2.53)   0.0
  Cemented    1,204   9.5   837   92 (91–94)   616  89 (87–91)   210   76 (72–79)   1.0 (reference)   –
  Subtotal   6,781         
65–74   
  Anatomic Mesh/HG-II   186   11.3   165   94 (90–97)   133  90 (86–95)   34   77 (67–87)   1.05 (0.70–1.56)   0.8 
   PCA Std/PCA Pegged   133   11.0   112   91 (86–96)   85  81 (74–88)   30   70 (61–80)   1.78 (1.23–2.58)   0.002
   Bi-Metric/PFU   740   8.5   525   94 (92–96)   320  90 (87–93)   45   85 (81–89)   0.89 (0.68–1.16)   0.4 
  Bi-Metric/Mallory   274   8.8   223   95 (92–98)   119  91 (87–95)   2   –   0.88 (0.57–1.34)   0.5
   Bi-Metric/Vision   850   3.1   51   94 (90–97)   0  –   0   –   1.10 (0.74–1.63)   0.6
   ABG I/ABG I   238   9.0   187   91 (87–95)   142  86 (81–91)   0   –   1.34 (0.93–1.92)   0.1
  ABG I/ABG II   789   5.9   311   98 (96–99)   8  –   0   –   0.48 (0.31–0.75)   0.001
   ABG II/ABG II   647   2.4   0   –   0  –   0   –   1.62 (1.05–2.51)   0.03   
  Cemented    4,964   9.3   3,446   94 (93–95)   2,635  90 (89–91)   722   85 (83–87)   1.0 (reference)   –
  Subtotal 8,821         
>75   
  Anatomic Mesh/HG-II   33   8.9   25   90 (80–100)   17  –   2   –   1.69 (0.54–5.32)   0.4
   PCA Std/PCA Pegged   28   7.6   18   –   8  –   1   –   2.44 (0.78–7.66)   0.1
  Bi-Metric/PFU   84   5.6   31   93 (86–99)   14  –   1   –   1.60 (0.65–3.90)   0.3
   Bi-Metric/Mallory   97   8.1  73   98 (95–100)   39   1   –     0.45 (0.11–1.80)   0.3
  Bi-Metric/Vision   125   2.8   6   –   0  –   0  –  2.09 (0.92–4.77)   0.08
  ABG I/ABG I   47   8.0   33   100 (100–100)   21  100 (100–100)   0   –   –   –
   ABG I/ABG II   230   5.6   82   97 (94–99)   1  –   0   –   0.70 (0.31–1.60)   0.4
   ABG II/ABG II   232   2.6   0   –   0  –   0   –   1.69 (0.85–3.35)   0.1
   Cemented    3,381   7.6   1,954   96 (95–97)   1,198  95 (94–96)   186   94 (92–95)   1.0 (reference)   –
   Subtotal   4,257         
All (≥ 55 years)  
  Anatomic Mesh/HG-II   604   11.1   532   94 (92–96)   446  89 (87–92)   93   72 (67–78)   1.19 (0.97–1.47)   0.1
     FU ≤ 7 years                           0.91 (0.64–1.29)   0.6
     FU > 7 years                           1.32 (1.01–1.72)  0.04
   PCA Std/PCA Pegged   508   11.6   433   91 (89–94)   354 82 (79–86)  149   67 (62–72)   1.51 (1.24–1.83)  < 0.001
      FU ≤ 7 years                           1.26 (0.91–1.75)   0.2
      FU > 7 years                           1.52 (1.18–1.95)   0.001
   Bi-Metric/PFU   2,687   8.8   2,044   93 (92–94)   1,205  87 (86–89)   147   71 (67–75)   1.10 (0.95–1.27)   0.2
      FU ≤ 7 years                          0.98 (0.80–1.20)   0.8
      FU > 7 years                           1.18 (0.96–1.46)   0.1
   Bi-Metric/Mallory   637   8.8   519   95 (93–97)   277  89 (85–92)  10   –    1.05 (0.81–1.36)   0.7
     FU ≤ 7 years                           0.76 (0.52–1.12)   0.2
      FU > 7 years                           1.43 (1.00–2.05)   0.05
  Bi-Metric/Vision   2,055   3.4   153   95 (93–96)   0  –  0   –   0.99 (0.76–1.29)   0.9
      FU ≤ 7 years                           0.98 (0.75–1.29)   0.9
     FU > 7 years                          2.75 (0.38–19.9)  0.3
   ABG I/ABG I   565   9.1   458   91 (89–94)   336  81 (77–84)   0   –   1.74 (1.41–2.15)  < 0.001
      FU ≤ 7 years                          1.27 (0.92–1.74)   0.1
      FU > 7 years                           2.30 (1.73–3.06)  < 0.001
   ABG I/ABG II   1,765   5.9   701   96 (95–97)   14  –   0   –   0.66 (0.51–0.86)  0.002
      FU ≤ 7 years                           0.63 (0.48–0.84)  0.001
     FU > 7 years                          0.69 (0.28–1.69)   0.4
   ABG II/ABG II   1,489   2.5   0   –   0  –   0   –   1.52 (1.13–2.05)  0.006
      FU ≤ 7 years                           1.46 (1.08–1.97)   0.01
     FU > 7 years                           –   –
   Cemented    9,549   8.8   6,237   94 (94–95)   4,449  91 (91–92)   1,117   86 (84–87)   1.0 (reference)  –
     FU ≤ 7 years                           1.0 (reference)   –
      FU > 7 years                           1.0 (reference)   –
  Total   19,859     
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The  proportional  hazards  assumption  of  the  Cox  model 
(meaning that the relative difference between revision rates 
should  be  constant  over  time  since  the  primary  operation) 
was not reached in some analyses. Thus, adjusted risk ratios 
were also established within time intervals (0–7 years and > 7 
years after the primary operation). Follow-up beyond 7 years 
revealed that the results of cementless cups, and therefore of 
cementless THRs, detoriate with time. 
The revision rates that we found for cementless implants 
were similar to previous findings (Malchau et al. 1997, Than-
ner et al. 1999, Xenos et al. 1999, Archibeck et al. 2001, Puo-
lakka et al. 2001b, Giannikas et al. 2002, Bojescul et al. 2003, 
Jacobsen et al. 2003, Duffy et al. 2004, Herrera et al. 2004, 
Marshall et al. 2004, Moskal et al. 2004, Oosterbos et al. 2004, 
Kim 2005, Eskelinen et al. 2006, Castoldi et al. 2007, Fires-
tone et al. 2007, Surdam et al. 2007).
 We found a higher long-term survival rate for the Bi-Metric 
stem than for the reference stems in patients aged 55–74 years. 
When revisions for aseptic loosening were analyzed, the Press-
Fit Universal cup was found to have a long-term survival rate 
similar to those of the reference cups in patients aged 55–74 
years. In Finland, Biomet cups were used with Hexloc liners 
until 1995, and with Ringloc liners after that. In an earlier 
study based on data from the Finnish Register, survivorship 
of the Press-Fit Universal cups with Hexloc liners was poor 
(Puolakka et al. 1999). Reasons for increased wear of Hexloc 
liners were thin polyethylene, poor quality of the polyethylene, 
cylindrical design, and a poor locking mechanism (Puolakka 
et al. 1999, 2001b). Furthermore, the screw-holes of Press-
Fit Universal cups were unplugged. In the present study, the 
survival rate of the Bi-Metric/Press-Fit Universal at 15 years 
was lower than that of the cemented reference group when 
all revisions were taken into account. However, the adjusted 
risk of revision of the Bi-Metric/Press-Fit Universal for any 
reason was similar to that of the reference group. This finding 
is probably influenced by the positive effect of Ringloc liners 
(starting in 1995) on the results with the Bi-Metric/Press-Fit 
Universal. Unfortunately, it is not possible to analyze the sur-
vival rate of the Press-Fit Universal cups with Hexloc liners 
and  with  Ringloc  liners  separately  in  the  Finnish  Register 
data. Revision risk for any reason with the Bi-Metric/Vision 
was similar to that for the cemented reference group (Table 7, 
Figure 2B). However, survival rates at 10-years for the Vision 
cup with Ringloc-liners and plugged screw-holes are not yet 
available. 
The  survival  rate  for  aseptic  loosening  of  the Anatomic 
Mesh/Harris-Galante II at 15 years was not significantly dif-
ferent from that of the cemented reference group. Nonetheless, 
the survival rate of the Anatomic Mesh/HG-II for any reason 
at 15 years was poor. Again, this finding can be attributed to 
wear-related factors. The Anatomic Mesh/Harris-Galante II is 
no longer being implanted in patients in Finland.
The 15-year survival rate for the PCA Standard stem in our 
study was lower than those for the best-performing stems. 
The PCA Standard/PCA Pegged prosthesis is no longer being 
implanted in patients in Finland.
The 10-year survival rate of the ABG I/ABG I for any reason 
was lower than that for the reference group. However, the sur-
vival rate of the ABG I stem at 10 years for aseptic loosening 
was higher than that for the reference group. For this reason, 
and because of poor liners in the ABG I cup design, in Finland 
the ABG I stem has been widely used along with the ABG 
II cup with plugged screw-holes and thicker Duration liners 
consisting of stabilized polyethylene (Stryker, Mahwah, NJ). 
In our study, the risk of revision of the ABG I/ABG II for 
any reason in patients aged 65–74 was lower than that for the 
reference group when all revisions were taken into account 
(Table 7, Figure 2B). However, the survival rates for the ABG 
I/ABG II at 10 years are not yet available. Survivorship of 
modular cementless cups may dramatically worsen after 7–10 
years of follow-up due to excessive wear and osteolysis, as 
indicated by the beyond-7-years survival analysis in our study. 
Thus, it is too early to draw any definite conclusions about the 
long-term success of this hip implant.
The ABG II stem differs from the ABG I stem regarding 
its titanium alloy composition, its stem geometry, its mac-
rotexture, its conus size, and the option with Zirkonia heads 
(ABG II Cement-Free Hip System). The risk of revision of 
the ABG II/ABG II for any reason was higher than that for 
the reference group. The mean follow-up time for the ABG 
II/ABG II was short: only 2.5 years (Table 1). The proportion 
of periprothetic fractures for all revisions of the ABG II/ABG 
II was high: 37% (Table 3). This finding is in accordance with 
clinical experience in Finland. The ABG II stem appears to 
be vulnerable to perioperative periprothetic femoral fractures, 
due to its anatomical and conical shape. There were only 3 
aseptic loosenings of the ABG II stem during the study period 
(Table 3). The problem with an early aseptic loosening of a 
cementless stem is that there may not have been any osseoin-
tegration at all from the beginning, due to undersizing or some 
other technical failure. Thus, strictly speaking any associated 
loosening could not have happened either. A longer follow-up 
time is needed to determine whether either the ABG I/ABG 
II or the ABG II/ABG II provides a long-term solution to the 
wear problem. Only a few Zirkonia head or liner fractures 
have been reported in Finland (Table 3).
For patients aged 75 years and older, the survival rates were 
similar between cementless implants and the cemented refer-
ence group, except that the PCA Pegged cup had an increased 
risk of revision compared to the cemented reference group. 
This is in accordance with the results of a previous report from 
the Finnish Arthroplasty Register (Mäkelä et al. 2008a). How-
ever, there was little information for this subgroup.
In conclusion, cementless, proximal porous-coated stems 
are  a  good  option  for  elderly  patients.  Polyethylene  wear 
and osteolysis remain a problem for cementless designs with 
unplugged screw-holes and low-quality liners. Acta Orthopaedica 2010; 81 (1): 42–52  51
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